GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Dividend Payout Ratio

Dr. Lal PathLabs (NSE:LALPATHLAB) Dividend Payout Ratio : 1.18 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Dividend Payout Ratio?

Dr. Lal PathLabs's dividend payout ratio for the months ended in Mar. 2024 was 1.18.

The historical rank and industry rank for Dr. Lal PathLabs's Dividend Payout Ratio or its related term are showing as below:

NSE:LALPATHLAB' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15   Med: 0.34   Max: 0.58
Current: 0.56


During the past 13 years, the highest Dividend Payout Ratio of Dr. Lal PathLabs was 0.58. The lowest was 0.15. And the median was 0.34.

NSE:LALPATHLAB's Dividend Payout Ratio is ranked worse than
63.79% of 58 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.44 vs NSE:LALPATHLAB: 0.56

As of today (2024-05-19), the Dividend Yield % of Dr. Lal PathLabs is 0.94%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Dr. Lal PathLabs was 1.16%. The lowest was 0.21%. And the median was 0.50%.

Dr. Lal PathLabs's Dividends per Share for the months ended in Mar. 2024 was ₹12.00.

During the past 12 months, Dr. Lal PathLabs's average Dividends Per Share Growth Rate was 100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 26.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 21.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dr. Lal PathLabs was 60.50% per year. The lowest was -8.20% per year. And the median was 36.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Dr. Lal PathLabs Dividend Payout Ratio Historical Data

The historical data trend for Dr. Lal PathLabs's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Dividend Payout Ratio Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.34 0.34 0.42 0.56

Dr. Lal PathLabs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.92 - 1.18

Competitive Comparison of Dr. Lal PathLabs's Dividend Payout Ratio

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's Dividend Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Dividend Payout Ratio falls into.



Dr. Lal PathLabs Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Dr. Lal PathLabs's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=24/ 42.98
=0.56

Dr. Lal PathLabs's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=12/ 10.17
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr. Lal PathLabs (NSE:LALPATHLAB) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Dr. Lal PathLabs Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines